Table 2.
SBP (mm Hg) | DBP (mm Hg) | MABP (mm Hg) | HR (BPM) | |
---|---|---|---|---|
Normotensive control | 113.24 ± 2.85 | 81.63 ± 3.26 | 92.17 ± 3.11 | 345.61 ± 4.65 |
Hypertensive control | 189.49 ± 3.85a | 147.26 ± 5.40a | 161.34 ± 4.79a | 390.28 ± 16.45c |
LN + captopril | 147.18 ± 5.82α | 118.65 ± 5.35α | 128.16 ± 5.32α | 349.98 ± 8.27 |
LN + AD100 | 172.64 ± 1.61α | 135.77 ± 1.50β | 148.06 ± 1.40α | 349.48 ± 13.16 |
LN + AD200 | 149.07 ± 7.86α | 115.10 ± 6.73α | 126.42 ± 7.08α | 341.04 ± 19.20α |
Data are mean ± SEM (N = 6 per group). ANOVA + the Tukey test: cp < 0.05 and ap < 0.001 vs. the normotensive control group; δp < 0.05, βp < 0.01, and αp < 0.001 vs. the hypertensive control group. AD100/AD200 = extract doses 100 or 200 mg/kg. DBP = diastolic arterial blood pressure. HR = heart rate. LN = N-NAME. MABP = mean arterial blood pressure. SBP = systolic arterial blood pressure.